GET A QUOTE

Chlamydia Trachomatis IgG ELISA Kit

  • Created on the 12 July, 2017.

BACKGROUND

Chlamydia trachomatis has been described as one of the most common bacterial sexually transmitted infections worldwide and also women are regarded as carrying the major burden of the disease. Chlamydial infection has been found to result in casing a cause disease in a number of different organ systems, which includes the genitourinary tract. C. trachomatis is a strong immunogen, which can stimulate both cell mediated and humoral immune responses. The general outcome of the chlamydial infection is largely dependent on the overall balance and interaction of cytokines that have been secreted by the activated lymphocytes. IFN-γ is regarded as an important factor which is vital in the host defence against Chlamydia, while on the other hand the susceptibility to the disease has been associated with enhanced expression of IL-10. The means that the changes to the immune system or even any disturbances which have been induced by C. trachomatis could either favour its own survival in the infected host or it could induce persistent infections.

INTENDED USE

Human Chlamydia trachomatis-IgG ELISA kit is designed for analysing in-vitro quantitative concentrations of human IgA antibodies against Chlamydia trachomatis in serum and plasma samples. This assay has a minimum analytical sensitivity limit to a diagn. >95.0%.

SENSITIVITY

The minimum detection sensitivity level of human Chlamydia trachomatis IgG using this human Chlamydia trachomatis-IgG ELISA kit was to a diagn. >95.0%. The dynamic assay range for this kit is to a specific cut-off point.

REFERENCES

  1. Elevated serum Chlamydia trachomatis IgG antibodies. What do they mean for IVF pregnancy rates and loss? J Reprod Med. (1997) 42 (5): 281-6. Sharara F.I., et al.
  2. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology. Hum Reprod. (2011) 26 (11): 3061-7. Coppus S.F., et al.
  3. [Chlamydia trachomatis antigens in endocervical samples and serum IgG antibodies in sterile-infertile women using ELISA]. Mikrobiyol Bul. (1992) 26 (3): 203-13. Turkish. Cengiz L., et al.
  4. The value of Chlamydia trachomatis-specific IgG antibody testing and hysterosalpingography for predicting tubal pathology and occurrence of pregnancy. Fertil Steril. (2007) 88 (1): 224-6. Perquin D.A., et al.
  5. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections. Pathol Biol (Paris). (2008) 56 (3): 143-7. Frikha-Gargouri O., et al.

ADDITIONAL INFORMATION

  • Full Name: Chlamydia Trachomatis IgG ELISA Kit
  • Reactivity: Human
  • Sample Type: Plasma, Serum
  • Sensitivity: diagn. >90.0%

OTHER RELATED ELISA KITS

TESTIMONIALS arrow icon

Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford